ES2210219T3 - Derivados de octahidro-2h-pirido- (1,2-a) -pirazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen. - Google Patents
Derivados de octahidro-2h-pirido- (1,2-a) -pirazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.Info
- Publication number
- ES2210219T3 ES2210219T3 ES02291745T ES02291745T ES2210219T3 ES 2210219 T3 ES2210219 T3 ES 2210219T3 ES 02291745 T ES02291745 T ES 02291745T ES 02291745 T ES02291745 T ES 02291745T ES 2210219 T3 ES2210219 T3 ES 2210219T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- compounds
- pyrido
- octahydro
- linear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0109260 | 2001-07-12 | ||
FR0109260A FR2827288B1 (fr) | 2001-07-12 | 2001-07-12 | Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2210219T3 true ES2210219T3 (es) | 2004-07-01 |
Family
ID=8865405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES02291745T Expired - Lifetime ES2210219T3 (es) | 2001-07-12 | 2002-07-11 | Derivados de octahidro-2h-pirido- (1,2-a) -pirazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen. |
Country Status (24)
Country | Link |
---|---|
US (1) | US6992085B2 (enEXAMPLES) |
EP (1) | EP1275647B1 (enEXAMPLES) |
JP (1) | JP3950018B2 (enEXAMPLES) |
KR (1) | KR100485020B1 (enEXAMPLES) |
CN (1) | CN1197863C (enEXAMPLES) |
AR (1) | AR036166A1 (enEXAMPLES) |
AT (1) | ATE254124T1 (enEXAMPLES) |
AU (1) | AU2002300094B2 (enEXAMPLES) |
BR (1) | BR0202681A (enEXAMPLES) |
CA (1) | CA2394027C (enEXAMPLES) |
DE (1) | DE60200089T2 (enEXAMPLES) |
DK (1) | DK1275647T3 (enEXAMPLES) |
EA (1) | EA005160B1 (enEXAMPLES) |
ES (1) | ES2210219T3 (enEXAMPLES) |
FR (1) | FR2827288B1 (enEXAMPLES) |
HU (1) | HUP0202282A3 (enEXAMPLES) |
MX (1) | MXPA02006699A (enEXAMPLES) |
NO (1) | NO322966B1 (enEXAMPLES) |
NZ (1) | NZ520120A (enEXAMPLES) |
PL (1) | PL355034A1 (enEXAMPLES) |
PT (1) | PT1275647E (enEXAMPLES) |
SI (1) | SI1275647T1 (enEXAMPLES) |
TR (1) | TR200302001T4 (enEXAMPLES) |
ZA (1) | ZA200205596B (enEXAMPLES) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1611902A4 (en) * | 2003-04-03 | 2006-04-12 | Kyowa Hakko Kogyo Kk | MEANS FOR THE PREVENTION AND / OR TREATMENT OF NEUROPATHIC PAIN |
MY141255A (en) * | 2003-12-11 | 2010-03-31 | Memory Pharm Corp | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP2008503560A (ja) * | 2004-06-22 | 2008-02-07 | ファイザー・プロダクツ・インク | ジアザビシクロ系のヒスタミン−3受容体アンタゴニスト |
AU2006264966B2 (en) * | 2005-07-04 | 2013-02-21 | High Point Pharmaceuticals, Llc | Histamine H3 receptor antagonists |
RU2442775C2 (ru) * | 2005-07-04 | 2012-02-20 | Хай Пойнт Фармасьютикалс, ЛЛС | Антагонисты гистаминовых н3-рецепторов |
DE602007011904D1 (de) * | 2006-03-10 | 2011-02-24 | Neurogen Corp | Piperazinyl-oxoalkyl-tetrahydroisochinoline und verwandte analoga |
KR100871691B1 (ko) | 2006-10-16 | 2008-12-05 | 삼성전자주식회사 | 병렬 비트 테스트 방법 및 그 방법을 사용하는 반도체메모리 장치 |
US10870660B2 (en) | 2016-07-28 | 2020-12-22 | Shionogi & Co., Ltd. | Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect |
CN111801330B (zh) | 2018-01-26 | 2024-04-05 | 盐野义制药株式会社 | 具有多巴胺d3受体拮抗作用的稠环化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3388128A (en) * | 1965-09-03 | 1968-06-11 | Allan R. Day | Substituted 1, 4-diazabicyclo [4. 4. 9] decanes |
GB8518236D0 (en) * | 1985-07-19 | 1985-08-29 | Beecham Group Plc | Compounds |
WO1994006794A1 (en) * | 1992-09-24 | 1994-03-31 | National Institutes Of Health | Aralkyl diazabicycloalkane derivatives for cns disorders |
WO1996010570A1 (en) * | 1994-09-30 | 1996-04-11 | Pfizer Inc. | NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES |
US6231833B1 (en) * | 1999-08-05 | 2001-05-15 | Pfizer Inc | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
ES2274795T3 (es) * | 1999-07-19 | 2007-06-01 | Merck Frosst Canada Ltd. | Pirazinonas, composiciones que contienen tales compuestos. |
-
2001
- 2001-07-12 FR FR0109260A patent/FR2827288B1/fr not_active Expired - Fee Related
-
2002
- 2002-07-05 MX MXPA02006699A patent/MXPA02006699A/es active IP Right Grant
- 2002-07-10 JP JP2002201793A patent/JP3950018B2/ja not_active Expired - Fee Related
- 2002-07-11 TR TR2003/02001T patent/TR200302001T4/xx unknown
- 2002-07-11 NO NO20023345A patent/NO322966B1/no not_active IP Right Cessation
- 2002-07-11 ES ES02291745T patent/ES2210219T3/es not_active Expired - Lifetime
- 2002-07-11 SI SI200230005T patent/SI1275647T1/xx unknown
- 2002-07-11 DK DK02291745T patent/DK1275647T3/da active
- 2002-07-11 NZ NZ520120A patent/NZ520120A/en unknown
- 2002-07-11 EA EA200200663A patent/EA005160B1/ru not_active IP Right Cessation
- 2002-07-11 AT AT02291745T patent/ATE254124T1/de not_active IP Right Cessation
- 2002-07-11 EP EP02291745A patent/EP1275647B1/fr not_active Expired - Lifetime
- 2002-07-11 BR BR0202681-3A patent/BR0202681A/pt not_active IP Right Cessation
- 2002-07-11 PT PT02291745T patent/PT1275647E/pt unknown
- 2002-07-11 DE DE60200089T patent/DE60200089T2/de not_active Expired - Fee Related
- 2002-07-12 PL PL02355034A patent/PL355034A1/xx not_active Application Discontinuation
- 2002-07-12 HU HU0202282A patent/HUP0202282A3/hu unknown
- 2002-07-12 US US10/195,019 patent/US6992085B2/en not_active Expired - Fee Related
- 2002-07-12 CN CNB021241481A patent/CN1197863C/zh not_active Expired - Fee Related
- 2002-07-12 CA CA002394027A patent/CA2394027C/fr not_active Expired - Fee Related
- 2002-07-12 KR KR10-2002-0040727A patent/KR100485020B1/ko not_active Expired - Fee Related
- 2002-07-12 AU AU2002300094A patent/AU2002300094B2/en not_active Ceased
- 2002-07-12 ZA ZA200205596A patent/ZA200205596B/xx unknown
- 2002-07-12 AR ARP020102607A patent/AR036166A1/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1882541B (zh) | N-[苯基(烷基-2-哌啶基)甲基]苯甲酰胺衍生物,其制备和治疗用途 | |
US5583149A (en) | Antimigraine derivatives of indolylcycloalkanylamines | |
ZA200208504B (en) | Muscarinic agonists. | |
JPH08333363A (ja) | インドール誘導体 | |
IL109234A (en) | Indole derivatives, their preparation and pharmaceutical compositions containing them | |
US20130210827A1 (en) | Novel benzenesulfonamides as calcium channel blockers | |
MXPA00007058A (es) | Nuevos compuestos de -carbolina, un proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
ES2210219T3 (es) | Derivados de octahidro-2h-pirido- (1,2-a) -pirazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen. | |
US7947714B2 (en) | Piperidine glycine transporter inhibitors | |
US20090029979A1 (en) | 5-htx modulators | |
EP1003739A2 (en) | 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives | |
US7446123B2 (en) | Azabicyclo derivatives as muscarinic receptor antagonists | |
CN100406009C (zh) | 作为毒蕈碱受体拮抗剂的取代的氮杂双环己烷衍生物 | |
ES2552463T3 (es) | Compuestos aromáticos de sulfona útiles para el tratamiento de enfermedades del sistema nervioso central | |
JP4505135B2 (ja) | D2及びd3ドーパミンならびに5ht1a及び5ht2セロトニンのレセプターのリガンドとしての8−アザビシクロ[3.2.1]オクタン−3−メタンアミン誘導体 | |
US20080108663A1 (en) | Cyclopropyl Piperidine Glycine Transporter Inhibitors | |
FI94863B (fi) | Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi | |
WO1998042710A1 (fr) | Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique | |
CN1161696A (zh) | 作为nmda拮抗剂的杂环取代的丙烯酸衍生物 | |
WO2004080965A1 (ja) | ニューロペプチドff受容体拮抗剤 | |
EP0746556B1 (en) | Tricyclic compounds having affinity for the 5-ht1a receptor | |
KR20010086462A (ko) | 오피에이트 수용체 리간드로서의 3-아자비시클로[3.1.0.]헥산 유도체 | |
KR20050023400A (ko) | 무스카린 수용체 길항제로서의 아자비시클로 유도체 |